Literature DB >> 12098764

Analysis of phosphorylation of YJL084c, a yeast protein.

Xiao-Zhong Shi1, Shi-Zhou Ao.   

Abstract

PCL6, PCL7(PAP1), and PHO80 belong to the PHO80 subfamily of PCLs (PHO85 cyclins), share high homology in protein sequences, and function with some similarity. YLR190w, the substrate of PCL7-PHO85, shares homology with YJL084c in a 140-amino-acid region. In addition, YJL084c was reported as a PCL6-binding protein. Here, it was found that there was association between YJL084c and PCL7, and their interaction was confirmed by co-immunoprecipitation assay and GST pull-down assay. The in vitro translational product of YJL084c could be phosphorylated by PCL7-PHO85 complex. Also, the GST fusion protein of the middle region expressed in E.coli could be phosphorylated, while the amino terminal or the carboxyl terminal could not. Interestingly, PCL6-PHO85 complex had the same characters; effect of phosphate condition on the phosphorylation was shown in both PCL6-PHO85 and PCL7-PHO85. YPH499: Yjl084c :: LEU2 was constructed by homologous recombination. PUT4 was reported as a YJL084c-binding protein, but no difference was observed between wild strain and the Yjl084c null mutant on MP medium. In addition, the interaction between PHO81 and all of the three cyclins was analyzed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098764

Source DB:  PubMed          Journal:  Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)        ISSN: 0582-9879


  2 in total

1.  Endocytosis of the aspartic acid/glutamic acid transporter Dip5 is triggered by substrate-dependent recruitment of the Rsp5 ubiquitin ligase via the arrestin-like protein Aly2.

Authors:  Riko Hatakeyama; Masao Kamiya; Terunao Takahara; Tatsuya Maeda
Journal:  Mol Cell Biol       Date:  2010-10-18       Impact factor: 4.272

Review 2.  AMPK-Mediated Regulation of Alpha-Arrestins and Protein Trafficking.

Authors:  Allyson F O'Donnell; Martin C Schmidt
Journal:  Int J Mol Sci       Date:  2019-01-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.